Thierry Thomas

TL;DR: In postmenopausal women with osteoporosis who were at high risk for fracture, romosozumab treatment for 12 months followed by alendronsate resulted in a significantly lower risk of fracture than alendronate alone.

TL;DR: In this paper, the authors determined factors associated with COVID-19-related death in people with rheumatic diseases, including age, sex, smoking status, comorbidities, diagnosis, disease activity and medications.

TL;DR: In this article, the authors investigated whether treatment with rituximab is associated with severe COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases.

TL;DR: This series confirmed that the clinical manifestations of ISI usually lead to delayed diagnosis, and suggested performing an MRI of the spine and SI in clinical situations characterised by lumbogluteal pain and symptoms of an infectious disease, such as fever.

TL;DR: An overview of the consequences, determinants and potential solutions to poor adherence and persistence to osteoporosis medication is provided to help clinicians to manage adherence of their patients and to researchers and policy makers to design, facilitate and appropriately use adherence interventions.